CeFURoxime axetil

CeFURoxime axetil


General Information

  • High concentration in biliary tract thus potential for affecting gut flora

  • C. difficile risk is medium

  • Potential for dysbiosis of microbiome (decreased diversity, colonization with ESBL)

  • Thrush, vaginal candida infections

  • Diarrhea

Concentration: 25 mg/mL

Taste: Unpleasant taste

Not all strengths of oral liquids are listed nor be available on the CHEO Formulary

  • 250 mg
  • 500 mg

Tablets or capsules are preferred especially over an unpleasant tasting oral liquid.

Not all strengths of oral tablets/capsules are listed and they are not all available on the CHEO Formulary.